Status
Conditions
Treatments
About
The specific study aims will be:
Full description
Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems & Feasibility Study
Sixteen patients with stroke will be recruited in this phase Ⅰ study. During the pilot testing, each stroke patient will use each of the VR+MT and MR+MT systems with the assistance of a researcher holding the occupational therapist certification. The order of the feasibility test of the 2 systems will be counterbalanced across the patients. At the end of the feasibility study of each system, the patients will be asked to complete the System Usability Scale, Virtual Reality Sickness Questionnaire, and a self-designed questionnaire to assess the user experience and perspective about these new systems and their view of its suitability for stroke patients.
Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy
This three-arm, single-blind, randomized controlled trial will investigate the treatment effects among the 3 groups of VR+MT, MR+MT, and traditional MT. An estimated 45 patients with stroke will be recruited to participate in this phase Ⅱ study. Each participant will receive a total of 15 training sessions (40 minutes per session) within 5 weeks. Clinical outcome measures will be conducted at baseline, at immediately after treatment, and at 1 month follow-up after treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems & Feasibility Study
Inclusion Criteria:
Exclusion Criteria:
Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy
Inclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
45 participants in 3 patient groups
Loading...
Central trial contact
Yu-Wei Hsieh, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal